NBO Pharma Inc.

New Filing
CIK: 0002103906·Pharmaceuticals·DELAWARE·Filed: Jan 22, 2026
Total Offering

$7,640,217

Amount Sold

$7,640,217

Investors

93

First Sale

Jun 12, 2025

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(c)

Related Persons

NameRole
Fredric David Price
Executive Officer, Director
Robert Friedman
Director
Colin Foster
Director
Bard Geesaman
Director

Company

NBO Pharma Inc.

64 QUARRY LANE

BEDFORD, NY, 10506

914-645-1130

SEC Filing

0002103906-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free